Insulin resistance is related to impaired lung function in morbidly obese women: A case-control study

Diabetes/Metabolism Research and Reviews

Volumn 26, Issue 8, 2010, Pages 639-645

  Lecube, Albert ^a   Sampol, Gabriel ^a   Muñoz, Xavier ^a   Lloberes, Patricia ^a   Hernández, Cristina ^a   Simó, Rafael ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Insulin resistance; Obesity; Pulmonary function

Indexed keywords

INSULIN;

ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG INSUFFICIENCY; LUNG VOLUME; MAJOR CLINICAL STUDY; MORBID OBESITY; MULTIPLE LINEAR REGRESSION ANALYSIS; PREDICTION; PRIORITY JOURNAL; SMOKING; SPIROMETRY; TOTAL LUNG CAPACITY; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HUMANS; INSULIN RESISTANCE; LUNG; MIDDLE AGED; OBESITY, MORBID; PULMONARY DIFFUSING CAPACITY;

EID: 78049485520     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1131     Document Type: Article

References (32)

1. Barrett-Connor E, Frette C. NIDDM, impaired glucose tolerance, and pulmonary function in older adults. The Rancho Bernardo Study. Diabetes Care 1996; 19(12): 1441-1444.
2. Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2000; 50(2): 153-159.
3. Yeh HC, Punjabi NM, Wang NY, et al. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2008; 31(4): 741-746.
4. Nicolaie T, Zavoianu C, Nuta P. Pulmonary involvement in diabetes mellitus. Rom J Intern Med 2003; 41(4): 365-374.
5. Davis WA, Knuiman M, Kendall P, Grange V, Davis TM; Fremantle Diabetes Study. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004; 27(3): 752-757.
6. McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung: epidemiology. Thorax 2008; 63(7): 649-654.
7. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107(11): 1514-1519.
8. Fernandez-Real JM, Broch M, Ricart W, et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998; 47(11): 1757-1762.
9. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286(3): 327-334.
10. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370(9596): 1453-1457.
11. Lecube A, Sampol G, Lloberes P, et al. Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study. PloS ONE 2009; 4(3): e4692.
12. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003; 139(10): 802-809.
13. Ascaso JF, Romero P, Real JT, Priego A, Valdecabres C, Carmena R. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med Clin (Barc) 2001; 117(14): 530-533.
14. Carey MA, Card JW, Voltz JW, Germolec DR, Korach KS, Zeldin DC. The impact of sex and sex hormones on lung physiology and disease: lessons from animal studies. Am J Physiol Lung Cell Mol Physiol 2007; 293(2): L272-L278.
15. Card JW, Zeldin DC. Hormonal influences on lung function and response to environmental agents: lessons from animal models of respiratory disease. Proc Am Thorac Soc 2009; 6(7): 588-595.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005; 28(Suppl. 1): S37-S42.
17. Quanjer PH, Tammeling GJ, Cotes LE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 5-40.
18. Roca J, Sanchis J, Agusti-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22(3): 217-224.
19. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163(5): 1256-1276.
20. Gold WM. Pulmonary function testing. In Textbook of Respiratory Medicine (3rd edn), Murray JF, Nadel JA, Mason RJ, Boushey HA (eds). Elsevier Saunders: Philadelphia, 2000; 781-881.
21. Esnaola S, Duran J, Infante-Rivard C, Rubio R, Fernández A. Diagnostic accuracy of a portable device (Mesam IV) in suspected sleep apnoea. Eur Respir J 1996; 9: 2597-2605.
22. Lloberes P, Sampol G, Levy G, et al. Influence of setting on unattended respiratory monitoring in the sleep apnoea-hypopnoea syndrome. Eur Respir J 2001; 16: 530-534.
23. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118(3): 656-664.
24. Fernández-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia 1999; 42(11): 1367-1374.
25. Lawlor DA, Ebrahim S, Smith GD. Associations of measures of lung function with insulin resistance and type 2 diabetes: findings from the British Women's Heart and Health Study. Diabetologia 2004; 47(2): 195-203.
26. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 2004; 350(7): 664-671.
27. Morino K, Petersen KF, Shulman GI. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 2006; 55(Suppl. 2): S9-S15.
28. Lazarus R, Sparrow D, Weiss ST. Handgrip strength and insulin levels: cross-sectional and prospective associations in the Normative Aging Study. Metabolism 1997; 46(11): 1266-1269.
29. Hohlfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airways disease. Eur Respir J 1997; 10(2): 482-491.
30. Fernández-Real JM, Chico B, Shiratori M, Nara Y, Takahashi H, Ricart W. Circulating surfactant protein A (SP-A), a marker of lung injury, is associated with insulin resistance. Diabetes Care 2008; 31(5): 958-963.
31. Ahrén B. GLP-1 and extra-islet effects. Horm Metab Res 2004; 36(11-12): 842-845.
32. Bullo M, García-Lorda P, Salas-Salvadó J. Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal-weight and obese women: effect of adiposity and diabetes. Eur J Endocrinol 2002; 146(3): 325-331.